SULFACETAMIDE SODIUM Drug Patent Profile
✉ Email this page to a colleague
When do Sulfacetamide Sodium patents expire, and when can generic versions of Sulfacetamide Sodium launch?
Sulfacetamide Sodium is a drug marketed by Fougera Pharms, Padagis Us, Taro, Alcon Pharms Ltd, Bausch And Lomb, Epic Pharma Llc, Pharmafair, Sandoz, Sciegen Pharms Inc, and Genus. and is included in twelve NDAs.
The generic ingredient in SULFACETAMIDE SODIUM is prednisolone sodium phosphate; sulfacetamide sodium. There are eighty-eight drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the prednisolone sodium phosphate; sulfacetamide sodium profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SULFACETAMIDE SODIUM?
- What are the global sales for SULFACETAMIDE SODIUM?
- What is Average Wholesale Price for SULFACETAMIDE SODIUM?
Summary for SULFACETAMIDE SODIUM
| US Patents: | 0 |
| Applicants: | 10 |
| NDAs: | 12 |
| Finished Product Suppliers / Packagers: | 11 |
| Raw Ingredient (Bulk) Api Vendors: | 67 |
| Clinical Trials: | 2 |
| Patent Applications: | 21 |
| DailyMed Link: | SULFACETAMIDE SODIUM at DailyMed |
Recent Clinical Trials for SULFACETAMIDE SODIUM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Chang Gung Memorial Hospital | Phase 1/Phase 2 |
| Sidney Kimmel Cancer Center at Thomas Jefferson University | N/A |
Pharmacology for SULFACETAMIDE SODIUM
| Drug Class | Sulfonamide Antibacterial |
Medical Subject Heading (MeSH) Categories for SULFACETAMIDE SODIUM
Anatomical Therapeutic Chemical (ATC) Classes for SULFACETAMIDE SODIUM
US Patents and Regulatory Information for SULFACETAMIDE SODIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fougera Pharms | SULFACETAMIDE SODIUM | sulfacetamide sodium | LOTION;TOPICAL | 077015-001 | Nov 17, 2006 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Epic Pharma Llc | SULFACETAMIDE SODIUM | sulfacetamide sodium | SOLUTION/DROPS;OPHTHALMIC | 040216-001 | May 25, 1999 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Padagis Us | SULFACETAMIDE SODIUM | sulfacetamide sodium | OINTMENT;OPHTHALMIC | 080029-001 | Approved Prior to Jan 1, 1982 | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Genus | SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE | prednisolone sodium phosphate; sulfacetamide sodium | SOLUTION/DROPS;OPHTHALMIC | 073630-001 | May 27, 1993 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pharmafair | SULFACETAMIDE SODIUM | sulfacetamide sodium | SOLUTION/DROPS;OPHTHALMIC | 088947-001 | May 17, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Padagis Us | SULFACETAMIDE SODIUM | sulfacetamide sodium | LOTION;TOPICAL | 078649-001 | Mar 23, 2009 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Taro | SULFACETAMIDE SODIUM | sulfacetamide sodium | LOTION;TOPICAL | 078668-001 | May 20, 2009 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
